Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RETRACTED: Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
Shahin Hallaj, Sima Heydarzadeh Asl, Fatemeh Alian, et al.
Life Sciences (2020) Vol. 259, pp. 118150-118150
Closed Access | Times Cited: 25

Showing 25 citing articles:

Nanotechnology in ovarian cancer: Diagnosis and treatment
Mahmood Barani, Muhammad Bilal, Fakhara Sabir, et al.
Life Sciences (2020) Vol. 266, pp. 118914-118914
Closed Access | Times Cited: 154
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Life Sciences (2021) Vol. 277, pp. 119430-119430
Closed Access | Times Cited: 88
Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery
Magdalena Jurczyk, Katarzyna Jelonek, Monika Musiał‐Kulik, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 326-326
Open Access | Times Cited: 80
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, R. Nagarajan
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Shima Bastaki, A. Surendar, Nasrin Ahmadpour Saheb, et al.
Life Sciences (2020) Vol. 266, pp. 118847-118847
Closed Access | Times Cited: 64
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 275, pp. 119369-119369
Closed Access | Times Cited: 36
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 849-863
Closed Access | Times Cited: 34
Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics
Prateeksha, Vivek Sharma, Xiaowen Liu, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 706-731
Open Access | Times Cited: 30
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108288-108288
Closed Access | Times Cited: 27
Nanoparticles targeting the adenosine pathway for cancer immunotherapy
Kehua Jiang, Jian Wu, Qing Wang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 24, pp. 5787-5811
Closed Access | Times Cited: 3
Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth
Khalid Odamizil Alzamely, Farnaz Hajizadeh, Morteza Heydari, et al.
Colloids and Surfaces B Biointerfaces (2020) Vol. 197, pp. 111421-111421
Closed Access | Times Cited: 25
RETRACTED: Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 288, pp. 120166-120166
Closed Access | Times Cited: 21
Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
Materials Today (2022) Vol. 58, pp. 57-70
Closed Access | Times Cited: 15
Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer
Sima Emadi Allahyari, Farnaz Hajizadeh, Angelina Olegovna Zekiy, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 34, pp. 102384-102384
Closed Access | Times Cited: 18
Antisense oligonucleotides-Laden UiO-66@Au nanohybrid for enhanced radiotherapy against hypoxic tumor by dual-inhibition of carbonic anhydrase IX
Kai Wang, Shuaishuai Ding, Lijuan Zeng, et al.
Applied Materials Today (2021) Vol. 25, pp. 101201-101201
Closed Access | Times Cited: 15
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1851-1866
Closed Access | Times Cited: 9
Nano‐Engineering Strategies for Tumor‐Specific Therapy
Zijin Li, Hai‐Yan Xie, Weidong Nie
ChemMedChem (2024) Vol. 19, Iss. 10
Closed Access | Times Cited: 1
Adenosine: The common target between cancer immunotherapy and glaucoma in the eye
Shahin Hallaj, Mohammad Mirza‐Aghazadeh‐Attari, Amin Arasteh, et al.
Life Sciences (2021) Vol. 282, pp. 119796-119796
Closed Access | Times Cited: 9
Purinergic system in cancer stem cells
José David Núñez-Ríos, Henning Ulrich, Mauricio Díaz‐Muñoz, et al.
Purinergic Signalling (2023)
Open Access | Times Cited: 3
Modulating expression of inhibitory and stimulatory immune ‘checkpoints’ using nanoparticulate-assisted nucleic acid delivery
Adam A. Walters, Baljevan Dhadwar, Khuloud T. Al‐Jamal
EBioMedicine (2021) Vol. 73, pp. 103624-103624
Open Access | Times Cited: 8
RETRACTED ARTICLE: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response
Armin Mahmoud Salehi Kheshti, Farnaz Hajizadeh, Asal Barshidi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 2, pp. 353-367
Closed Access | Times Cited: 4
Enhancing Chemotherapy Efficacy: Investigating the Synergistic Impact of Paclitaxel and cd73 Gene Suppression on Breast Cancer Cell Proliferation and Migration
Farzaneh Hamidnia, Elif Sibel Aslan, Souzan Najafi, et al.
Cureus (2024)
Open Access
The potential of nanosystems in disrupting adenosine signaling pathways for tumor immunotherapy
Yutong Zhao, Jingqi Sun, Xiaoling Xu, et al.
Expert Opinion on Drug Delivery (2024), pp. 1-16
Closed Access
A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer
Sagari Sil, Janet Bertilla, S. Rupachandra
3 Biotech (2022) Vol. 13, Iss. 1
Closed Access | Times Cited: 1
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
SSRN Electronic Journal (2021)
Closed Access
Page 1

Scroll to top